Today at Haleon — currently the largest consumer health company in the world — Holahan’s role consists of being the general manager and marketing VP for household wellness brands such as Centrum, Emergen-C, ChapStick and Abreva. Part of leading these brands includes cross-functional collaboration with customer sales, innovation, supply chain and research and development, and these are exciting components of her responsibilities. Business development is also playing a role as well, as Haleon explores opportunities for growth.
“Part of the reason they continue to feed a lot of the business development my way is because I’ve had diverse experience, not just in marketing and leading a P&L, but in sales — I understand the operational side of it, having led that piece. In strategy, I led the digital strategy piece, so I understand the changing dynamics,” she said. “Diversification in my career has been very beneficial and opened up a lot of doors.”
With hands-on experience in acquisitions and integrations, Holahan discussed the stages that occur when a firm is assessing opportunities to see if they strategically align with their business, including opportunity identification, nonconfidential evaluation, business case and initial due diligence, confirmatory due diligence, agreement and execution/integration.
“We take a look at what we believe the business will be worth under our management. There are two places we look at in the valuation: top-line growth and synergy cost efficiency,” Holahan shared. “There are benefits top-line we can bring to the table. As a big company, we have access to all the big retailers and great relationships with them. We may be able to get distribution that [the smaller business] couldn’t get. As a big company, we have contracted rates with our manufacturing partners, so are there cost of goods synergies we could bring to the table? We have partnerships with media agencies, so could we purchase media for cheaper? Those all get factored into our valuation.”